Injectable / Growth Hormone & Performance
Tesamorelin
GHRH Analog · 5mg
$99 USD per unit · Coming soon · 5mg / 2mL vial
FDA-recognized GHRH analog targeting visceral adiposity. Clinical-grade growth hormone releasing hormone therapy.
Product information
Tesamorelin is a synthetic GHRH analog that stimulates the pituitary to produce and release endogenous growth hormone. It is the only GHRH analog with FDA recognition for lipodystrophy-related visceral adiposity.
By stimulating natural GH production rather than introducing exogenous hormone, tesamorelin supports physiological GH pulsatility while specifically targeting visceral fat reduction.
Benefits
- Visceral fat reduction
- Natural GH pulsatility
- FDA-recognized GHRH analog
- Pituitary-level activation
Specifications
- Fill / pack
- 5mg / 2mL vial
- Format
- Injectable
- Serving
- 2mg daily
- Servings per container
- 1 dose per vial
- Listed purity
- 99.5%
- Molecular weight / composition
- 5135.89 Da
- Storage
- Refrigerate 2-8°C
Frequently asked questions
How should I store this product?
Refrigerate at 2-8°C. Keep away from direct light. Once reconstituted, use within 30 days.
How long until I see results?
Most users report initial effects within 2-4 weeks, with optimal results typically observed after 8-12 weeks of consistent use. Individual responses vary.
Is a Certificate of Analysis included?
Yes. Every order includes a batch-specific COA with HPLC purity analysis, amino acid sequence verification, and endotoxin testing results.
What injection method is recommended?
Subcutaneous injection is standard. Rotate injection sites. Detailed protocol guidance is available on every product page.
For laboratory and research use only. Not for human consumption.
Browse all peptide bioregulators or the Growth Hormone & Performance collection. All formulations.